133 related articles for article (PubMed ID: 32341588)
1. Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.
Isozaki H; Yamamoto Y; Sakai K; Sho T; Ishihara K; Murakami S; Matsumoto S; Takama T
Acta Med Okayama; 2020 Apr; 74(2):137-143. PubMed ID: 32341588
[TBL] [Abstract][Full Text] [Related]
2. Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.
Tseng HS; Lin C; Chan SE; Chien SY; Kuo SJ; Chen ST; Chang TW; Chen DR
World J Surg Oncol; 2013 Jun; 11():139. PubMed ID: 23768133
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
4. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.
Park S; Koo J; Kim JH; Yang WI; Park BW; Lee KS
J Korean Med Sci; 2010 Mar; 25(3):361-8. PubMed ID: 20191033
[TBL] [Abstract][Full Text] [Related]
6. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.
Wu J; Ding S; Lin L; Fei X; Lin C; Andriani L; Goh C; Huang J; Hong J; Gao W; Zhu S; Wang H; Huang O; Chen X; He J; Li Y; Shen K; Chen W; Zhu L
Cancer Res Treat; 2020 Jul; 52(3):671-679. PubMed ID: 32019280
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Lei L; Yu X; Chen B; Chen Z; Wang X
PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognosis of mucinous breast carcinoma.
Zhang M; Teng XD; Guo XX; Zhao JS; Li ZG
J Cancer Res Clin Oncol; 2014 Feb; 140(2):265-9. PubMed ID: 24305754
[TBL] [Abstract][Full Text] [Related]
10. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and genomic features of breast mucinous carcinoma.
Lu K; Wang X; Zhang W; Ye H; Lao L; Zhou X; Yao S; Lv F
Breast; 2020 Oct; 53():130-137. PubMed ID: 32781417
[TBL] [Abstract][Full Text] [Related]
12. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
13. Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation.
Kato N; Endo Y; Tamura G; Katayama Y; Motoyama T
Pathol Int; 1999 Nov; 49(11):947-55. PubMed ID: 10594840
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
[TBL] [Abstract][Full Text] [Related]
15. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract][Full Text] [Related]
17. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
Gwark SC; Lee HS; Lee Y; Lee SB; Sohn G; Kim J; Chung IY; Ko BS; Kim HJ; Son BH; Ahn JH; Jung KH; Kim SB; Lee HJ; Gong GY; Ahn SH; Lee JW
Ann Surg Oncol; 2019 Jul; 26(7):2166-2174. PubMed ID: 30977015
[TBL] [Abstract][Full Text] [Related]
19. Tubular and mucinous breast cancer: results of a cohort of 917 patients.
Roux P; Knight S; Cohen M; Classe JM; Mazouni C; Chauvet MP; Reyal F; Colombo PE; Jouve E; Chopin N; Daraï E; Coutant C; Lambaudie E; Houvenaeghel G
Tumori; 2019 Feb; 105(1):55-62. PubMed ID: 30900967
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population-based study.
Yang LP; Sun HF; Zhao Y; Chen MT; Zhang N; Jin W
Cancer Med; 2017 Dec; 6(12):2867-2875. PubMed ID: 29131529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
